Venlafaxine Hydrochloride Tablet
Product Images NDC 0093-9147
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 0093-9147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This is a medication called Enlafaxine, with NDC (National Drug Code) number 0093-9147-01 and GTIN (Global Trade Item Number) 00300939147013. It is important to keep this medication in a dry and controlled room temperature place with a tight-resistant closure. The medication guides can be printed from the website www.tevausacom/medguides. It is manufactured in Czech Republic by Teva Czech Industries and made for Teva Pharmaceuticals located in Parsippany, NJ. The package contains 100 tablets and includes a serialization coding area. Pharmacists should provide the medication guide to each patient and it is only available with a prescription.*
1 (Image 3)
This is a medication called Venlafaxine Hydrochloride, which comes in a bottle with 100 tablets. Each tablet contains 37.5mg of venlafaxine. The medication is manufactured in the Czech Republic by Teva Czech Industries and distributed by Teva Pharmaceuticals in Parsippany, NJ. The medication guide is available on Teva's website, and pharmacists should dispense it to the patients. The label also contains storage instructions, including to keep it in a dry place at controlled room temperature. The text also mentions that the bottle has a child-resistant closure, and patients should keep the medication out of reach of children. There is also a serialization coding area.*
1 (Image 4)
This is a medication containing venlafaxine hydrochloride. Each tablet has 50mg of venlafaxine. The package insert should be consulted for more information on its use. The medication must be kept in a dry place at room temperature 77°F (25°C) . It is important to keep this, and all medication out of the reach of children. The manufacturer is Teva Pharmaceuticals and the medication comes with a serialization coding area. Printing of medication guides can be found at www.tevausaommedguides.com. GTIN is given as 0300939149017. There are 100 tablets inside and they should be dispensed with a child-resistant closure. The manufacturing location is Opava-Komarov in the Czech Republic.*
1 (Image 5)
This is a medication package from the company Teva. The package contains medication equivalent to 75 mg of venlafaxine. The package has a label that reads "SEALED FOR YOUR PROTECTION" and comes with a medication guide that should be given to each patient. The medication should only be dispensed by a pharmacist, and it is for prescription use only. The package has a National Drug Code of 0093-9157-01 and a Global Trade Item Number of 00300939157012. Dosage information is available in the package insert. The medication should be kept out of the reach of children, and it should be dispensed in a child-resistant container. The medication was manufactured in the Czech Republic by Teva Czech Industries.*
1 (Image 6)
This is a packaging of Venlafaxine Tablets stamped with "SEALED FOR YOUR PROTECTION". It contains 100 tablets of 100mg each. The medication guide that it comes with should be given to each patient. The usual dosage and other instructions for taking the medication can be found in the insert for information. The medication should be stored at 20°C to 25°C (68°F to 77°F) in a dry place away from children. It should be dispensed in a tight, light-resistant container. The manufacturer is Teva Czech Industries, sro and it is manufactured for Teva Pharmaceuticals in Parsippany, NJ. Serialization coding area includes Rev.D 9/2021 and 32056381-02. To see the package prescribing, refer to the website mentioned in the print Medication Guides.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.